Intensive care team reviewing monitors beside a ventilated patient
MYCOLY logo
MYCOLY

Mycology Learning Yard

Critical care mycology

Recognise invasive fungal disease before it outruns you.

Host risk, syndrome and trajectory stay primary while MYCOLY links biomarkers, imaging and species-level therapy.

8

body systems

18

published conditions

3

logic layers

24–48h

reassessment

MYCOLY — Mycology Learning Yard

Clinical clarity, from first spore to source control.

Syndromic reasoning stays primary while MYCOLY connects host risk, body systems, fungal pathogens, diagnostics and antifungal stewardship.

◉ Three explainable logic layers

01

Host risk & clinical features

Quick chips plus searchable features by body system, including rare and endemic mycoses relevant to Asia.

02

Deterministic rules

Matched input IDs, red flags and differentials — no unsourced dosing and no generated treatment presented as authoritative.

03

Source-versioned guidance

WHO FPPL, CDC, ISHAM/AFWG, NCDC India, ICMR, IDSA and ECMM records carry publisher, year and jurisdiction.

Educational decision support only

MYCOLY is not a medical device and does not provide autonomous diagnosis. Check every suggestion against local policy, allergy status, pregnancy, age, renal and hepatic function, mycology results and local antifungal resistance patterns. You are the data controller for anything you enter: use a lawful basis and appropriate consent, and follow your institution's confidentiality and retention rules. MYCOLY accepts no liability for clinical decisions taken from this output.

© 2026 MYCOLY · Mycology Learning Yard · mycoly.com

Sources: WHO · CDC · ISHAM & AFWG Asia · NCDC India · ICMR · IDSA · ECMM/ESCMID